<< Back to News

02/04/20 ks CLARIFICATION: Subcutaneous Haldol
February 4, 2020

From: "Karlette Stewart" <karlette.stewart@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Tuesday, February 4, 2020 2:46:35 PM
Subject: CLARIFICATION: Subcutaneous Haldol

CLARIFICATION: 

Haldol (haloperidol lactate) may be ordered via subcutaneous injection by any provider. Although SQ haldol is primarily ordered by palliative care providers, it IS NOT restricted to palliative care only. 

As a reminder, pharmacists should not automatically change the route on these orders, as this has not been approved by P&T. If you have concerns about the order route, please contact the provider. 

If you have any questions, please let me know. Thanks! 


----- Original Message -----
From: "Karlette Stewart" <karlette.stewart@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Tuesday, February 4, 2020 10:10:13 AM
Subject: Subcutaneous Haldol in Palliative Care


Pharmacists: 

This email is to alert all pharmacists responsible for inpatient order verification that Haldol (haloperidol lactate) can be administered via subcutaneous injection in palliative care ONLY. If you receive an order from any of the palliative care providers, please proceed with verification as you normally would. If you have concerns, the providers have asked that they be contacted prior to automatically changing the route. In the event you receive an order for a patient not followed by palliative care, it is recommended that the provider be contacted to suggest an alternative route per usual. 

If you have any questions, please let me know. Thanks!